- Report
- February 2025
- 150 Pages
Global
From €5296EUR$5,950USD£4,683GBP
- Report
- May 2025
- 200 Pages
Global
From €2216EUR$2,490USD£1,960GBP
- Report
- November 2025
- 278 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- January 2025
- 185 Pages
Global
From €4006EUR$4,500USD£3,542GBP
- Report
- November 2025
- 195 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 186 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 194 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 199 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 194 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- October 2025
- 194 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- October 2025
- 187 Pages
Global
From €3156EUR$3,545USD£2,790GBP
€3506EUR$3,939USD£3,100GBP
- Report
- November 2025
- 588 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 377 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 191 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 389 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 376 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 413 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 282 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 276 Pages
Global
From €5207EUR$5,850USD£4,604GBP
- Report
- November 2025
- 196 Pages
Global
From €5207EUR$5,850USD£4,604GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more